Cutaneous T-cell lymphoma, unspecified, in remission is a type of non-Hodgkin lymphoma characterized by the proliferation of T-lymphocytes in the skin. This condition can arise from various factors, including genetic predispositions and environmental triggers. Accurate coding with ICD-10 Code C84.AA is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that patients receive appropriate care and resources.
ICD-10 Code C84.AA represents Cutaneous T-cell lymphoma, unspecified, in remission, a malignancy of T-cells that primarily affects the skin. This code is used when the specific subtype of cutaneous T-cell lymphoma is not identified, but the patient is in remission. It is crucial for clinical documentation and billing to reflect the patient's current status accurately.
Cutaneous T-cell lymphoma, unspecified, in remission is a rare form of lymphoma that involves the skin and is characterized by the presence of malignant T-cells. The condition may progress from localized skin lesions to systemic involvement if left untreated, necessitating prompt medical attention.
ICD-10 Code C84.AA is utilized in SOAP notes to document the patient's remission status, symptoms, and treatment response. It plays a vital role in both acute and chronic care settings, ensuring comprehensive patient management and accurate billing.
In SOAP notes, ICD-10 Code C84.AA connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of cutaneous T-cell lymphoma in remission. This ensures continuity of care, supports billing, and meets EHR documentation standards.
Management of Cutaneous T-cell lymphoma, unspecified, in remission may involve various treatment modalities to maintain remission and manage symptoms.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C84.AA is critical for accurate billing in hospital, ER, or infectious disease care settings.
| CPT Code | Description |
|---|---|
| 96401 | Chemotherapy administration, intravenous, push technique. |
| 96920 | Photochemotherapy, including administration of photochemotherapeutic agent. |
| 99214 | Established patient office visit, moderate complexity. |
Common Questions About Using ICD-10 Code C84.AA for Cutaneous T-cell lymphoma, unspecified, in remission
What are the common symptoms of Cutaneous T-cell lymphoma?
Common symptoms include skin lesions that may appear as red patches or plaques, itching, and potential scaling. Patients may also experience discomfort or pain in affected areas.
How is Cutaneous T-cell lymphoma diagnosed?
Diagnosis typically involves a skin biopsy to examine the affected tissue for malignant T-cells. Clinical evaluation and patient history are also critical in confirming the diagnosis.
What treatments are available for Cutaneous T-cell lymphoma?
Treatment options may include topical corticosteroids, phototherapy, and systemic therapies. The choice of treatment depends on the severity and extent of the disease.
Is Cutaneous T-cell lymphoma contagious?
No, Cutaneous T-cell lymphoma is not contagious. It is a type of cancer that arises from the skin's T-cells and cannot be transmitted from person to person.
Clinical Notes
SOAP notes
DAP notes
AI medical notes